SCHEMBL736437

SCHEMBL736437

COc1ccc2[nH]c(C3=CCC(Cc4ccccc4)(N(C)C)CC3)c(C)c2c1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 6/20 0.46
MEN1 O00255 5/20 0.46
HTR7 P34969 2/20 0.41
HTR6 P50406 2/20 0.41
HTR1A P08908 2/20 0.41
HTR1D P28221 1/20 0.41
SLC6A4 P31645 1/20 0.41
HTR5A P47898 1/20 0.41
CFTR P13569 1/20 0.41
ALOX5 P09917 1/20 0.40
KDM4E B2RXH2 4/20 0.40
CYP1A2 P05177 2/20 0.40
CYP3A4 P08684 1/20 0.40
CYP2D6 P10635 1/20 0.40
ALOX15 P16050 1/20 0.40
HTR2A P28223 1/20 0.40
HTR2C P28335 1/20 0.40
CASP1 P29466 1/20 0.40
RECQL P46063 1/20 0.40
TDP1 Q9NUW8 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL734664 0.89 KIF11 (0.37) KMT2AMEN1CFTRALOX5KDM4E
SCHEMBL735918 0.87 OPRM1 (0.47) KMT2AMEN1HTR7HTR6HTR1A
SCHEMBL735032 0.86 OPRM1 (0.45) HTR7HTR6HTR2AHTR2CTDP1
SCHEMBL733731 0.84 OPRM1 (0.41) KMT2AMEN1SLC6A4OPRM1OGFRL1
SCHEMBL733828 0.84 OPRM1 (0.40) KMT2AMEN1OPRM1OGFRL1MDH2
SCHEMBL734337 0.83 ALOX5 (0.41) KMT2AMEN1HTR7HTR6HTR1A
SCHEMBL734296 0.81 OPRM1 (0.50) KMT2AMEN1HTR7HTR6HTR1A
SCHEMBL3932517 0.77 OPRM1 (0.47) KMT2AMEN1KDM4ECYP1A2CYP3A4
Hydrochloric Acid SCHEMBL734199 0.77 OPRM1 (0.46) KMT2AMEN1KDM4ECYP1A2CYP3A4
SCHEMBL736123 0.75 POLB (0.45) HTR6KDM4ECYP3A4HTR2AHTR2C

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2044016-B1 4-HETEROARYL-SUBSTITUTED 1-AMINOCYCLOHEXANE-1-AND CYCLOHEXENE-1-DERIVATIVES HAVING EFFECTS ON THE OPIOD RECEPTOR SYSTEM GRUENENTHAL GMBH (DE) 2012-12-05 EP disclosed
US-8138187-B2 Substituted heteroaryl derivatives GRUENENTHAL GMBH (DE) 2012-03-20 US disclosed
US-20100009986-A1 SUBSTITUTED HETEROARYL DERIVATIVES GRUNENTHAL GMBH (DE) 2010-01-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100009986-A1 SUBSTITUTED HETEROARYL DERIVATIVES CYP3A43, HMGCR, ABCG2 KMT2A 2453/4885MEN1 2253/4885HTR7 265/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.